Site of failure | Pre-op CRT, n(%) | Post-op CRT, n(%) | P ‡ | |
---|---|---|---|---|
Type of recurrence | LR alone | 17 (13.4) | 8 (8.1) | 0.573 |
LR with DM | 21 (16.5) | 15 (15.2) | ||
DM alone | 89 (70.1) | 76 (76.8) | ||
Total | 127 (100) | 99 (100) | ||
DM site* | Lung | 64 (48.1) | 44 (37.9) | 0.208 |
Liver | 24 (18.0) | 30 (25.9) | ||
PAN | 27 (20.3) | 20 (17.2) | ||
Others† | 18 (13.5) | 22 (19.0) | ||
Total | 133 (100) | 116 (100) | ||
Time to failure | Pre-op CRT, months | Post-op CRT, months | P ‡ | |
Type of recurrence | LR alone | 37.2 ± 21.2 | 35.2 ± 27.4 | 0.841 |
LR with DM | 25.6 ± 21.3 | 19.9 ± 13.3 | 0.372 | |
DM alone | 21.2 ± 15.9 | 19.1 ± 12.1 | 0.334 | |
Total | 24.1 ± 18.3 | 20.5 ± 14.5 | 0.112 | |
DM site* | Lung | 24.3 ± 18.2 | 20.1 ± 10.7 | 0.130 |
Liver | 16.5 ± 9.3 | 18.2 ± 14.1 | 0.597 | |
PAN | 18.8 ± 16.6 | 19.0 ± 13.5 | 0.964 | |
Others† | 21.5 ± 15.4 | 18.3 ± 13.9 | 0.494 |